(Q51369965)

English

Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia.

scientific article published in November 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

type 2 diabetes

0 references

1 reference

based on heuristic

inferred from title

Janusz Gumprecht

1

object named as

J Gumprecht

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

author name string

M Gosho

2

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

D Budinski

3

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

N Hounslow

4

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

publication date

1 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

13

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

11

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

1047-1055

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Standards of medical care in diabetes--2010.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Drug-drug interaction with statins.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Statin-associated myopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Pitavastatin: efficacy and safety in intensive lipid lowering

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Pitavastatin: a new HMG-CoA reductase inhibitor for the treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-dens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis pr

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

More Intensive Lipid Lowering is Associated with Regression of Coronary Atherosclerosis in Diabetic Patients with Acute Coronary Syndrome –Sub-Analysis of JAPAN-ACS Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

New evidence on pitavastatin: efficacy and safety in clinical studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Effects of pitavastatin (LIVALO Tablet) on high density lipoprotein cholesterol (HDL-C) in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Association of statins and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2011.01477.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2011.01477.X

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 April 2018

http://europepmc.org/abstract/MED/21812889

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51369965&oldid=2154850359"